Cryogenic Equipment Market Outlook (2022-2033)

Expansion of Biobanking and Advanced Therapies in Healthcare

A primary factor propelling the cryogenic equipment market is the swift growth of biobanking, regenerative medicine, cell and gene therapies, and vaccine storage all of which demand strong ultra-low temperature environments for biologic integrity. Cryogenic systems like liquid nitrogen tanks and ultra-low freezers are very important in the long-term preservation of cells, tissues, stem cells, and vaccines with very little degradation at the same time, thus, contributing to the research and clinical applications. The rise of biobanking projects around the world, such as the establishment of national and international specimen banks, indicates and supports ongoing healthcare demand for cryogenic facilities. Furthermore, personalized medicine and cell therapy research have more than doubled the demand for reliable, secure cold storage that could easily be a quality and regulatory compliance checkpoint for biological materials. The importance of having an efficient cold-chain in the medical field is further highlighted by the fact that cryo storage solutions are increasingly being seen in hospitals, labs, and biopharmaceutical companies everywhere in the world.

IoT-Enabled Innovations and Smart Cryogenic Solutions

Technological advancements in the cryogenic equipment market, such as IoT-enabled monitoring, automation, and real-time data analytics, are among the major opportunities that manufacturers will be able to tap into. Cryogenic storage units are being fitted with IoT sensors and cloud-based diagnostic systems by manufacturers, and this entails predictive maintenance, remote temperature tracking, and automated alerts. This shift not only benefits operational efficiency but also minimizes the amount of time that equipment is not functioning and improves sample safety--an aspect that is unavoidable when it comes to dealing with biological materials in hospitals, research labs, and biobanks. Monitoring done in real-time is one way to ensure that temperature changes which would otherwise spoil the samples are not allowed to happen, which is very crucial healthcare quality and regulatory issues. Moreover, the innovations in cryogenic devices that are portable and connected have opened up the opportunities for application in decentralized healthcare settings, thereby leading to vaccine distribution networks, where cold-chain solutions are vital. All these developments not only facilitate differentiated offerings but also attract healthcare adopters that are in need of better traceability; and thus, create new revenue streams for manufacturers focused on smart, connected cryogenic infrastructure.

The " Cryogenic Equipment Market Size and Forecast (2022 - 2033)" report provides a detailed analysis of the market covering below areas:

• Cryogenic equipment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Cryogenic equipment market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Cryogenic equipment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cryogenic equipment market
• Detailed company profiles, including SWOT analysis

The geographical scope of the cryogenic equipment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East and Africa, and South and Central America. The cryogenic equipment market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific cryogenic equipment market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. The Asia-Pacific cryogenic equipment market is experiencing robust growth, due to several interrelated factors that reflect both expanding healthcare infrastructure and increasing demand for advanced medical services. Increasingly, China, India, Japan, and South Korea are modernizing their healthcare facilities, and as a result, more cryogenic techniques are being utilized for the storage of vaccines, biological specimens, blood products, and clinical trial materials. The region's governments and private practitioners are pouring huge sums into building biobanks and research establishments that are centered around stem cell, regenerative, and customized treatments which all are reliant on ultra-low temperature storage. The surge in infectious disease studies and the necessity of strong vaccine cold chains has been accentuated during the recent pandemics and have thus, brought about the need for reliance on cryogenic freezers and liquid nitrogen tanks.

Besides, the growing biotechnology and pharmaceutical manufacturing presence of the region has created the demand for cryogenic systems that would ensure product quality and compliance with regulations. Additionally, the rise of public and private medical research funding as well as access to healthcare in rural and urban areas are among the factors that are driving hospitals, and diagnostic labs to upgrade their cryogenic inventory, thus, resulting in the continuous growth of the market across the Asia-Pacific healthcare sector.

• The report includes qualitative and quantitative data in the cryogenic equipment market across type, equipment, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the cryogenic equipment market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the cryogenic equipment market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the cryogenic equipment market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover cryogenic equipment market segments by type, equipment, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market revenue forecast and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the cryogenic equipment market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The cryogenic equipment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the cryogenic equipment market are:

• In March 2024, IC Biomedical took the lead as the very first cryogenic equipment manufacturer to be awarded the new upgraded European MDR Certification. This event coincided with their participation in the Laborama in Brussels, where they collaborated with their distribution partner, Linde Gas Benelux. The latter was presenting the company's latest Revolution freezer and was informing the visitors about its cutting-edge features along with the company's very high standards of safety and compliance.
• In January 2025, the operating subsidiary of Dover Corporation, PSG, made a public announcement, that it has taken over Cryogenic Machinery Corp., which specializes in the design and production of cryogenic centrifugal pumps, mechanical seals, and accessories used for the industrial gas market, and cryogenic applications of liquefied oxygen, argon, and nitrogen. The acquisition of Cryo-Mach’s products will allow PSG to strengthen its position in the cryogenic end market.